NEPHROS INC - Common Stock - $0.001 par value (NEPH)

CUSIP: 640671400

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
10,630,964
Total 13F shares
5,370,279
Share change
+66,716
Total reported value
$16,003,262
Price per share
$2.98
Number of holders
27
Value change
-$116,419
Number of buys
7
Number of sells
17

Security key

640671400

Report period

Q1 2026

Institutions

27

Top holders

10

Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Topline Capital Management, LLC
13F 13D/G
Company
5.6%
from 13D/G
614,302
$2,997,794 31 Dec 2025
WEXFORD CAPITAL LP
13F 3/4/5
Company · 10%+ Owner
34%
3,617,033
$17,651,117 31 Dec 2025
VANGUARD GROUP INC
13F
Company
2.2%
233,644
$1,140,183 31 Dec 2025
13F
BARD ASSOCIATES INC
13F
Company
1.1%
121,619
$593,501 31 Dec 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.98%
103,772
$506,407 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.7%
74,628
$364,278 31 Dec 2025
13F
Cambridge Investment Research Advisors, Inc.
13F
Company
0.65%
69,149
$337,000 31 Dec 2025
13F
HighTower Advisors, LLC
13F
Company
0.56%
59,710
$291,385 31 Dec 2025
13F
Mesirow Financial Investment Management, Inc.
13F
Company
0.47%
50,000
$244,000 31 Dec 2025
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.37%
38,984
$190,242 31 Dec 2025
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.34%
36,249
$176,895 31 Dec 2025
13F
NAVELLIER & ASSOCIATES INC
13F
Company
0.26%
27,175
$132,614 31 Dec 2025
13F
De Lisle Partners LLP
13F
Company
0.24%
25,000
$122,000 31 Dec 2025
13F
Quadrature Capital Ltd
13F
Company
0.22%
23,004
$112,260 31 Dec 2025
13F
MARSHALL WACE, LLP
13F
Company
0.21%
21,983
$107,277 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
0.2%
21,617
$105,491 31 Dec 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.19%
20,710
$101,065 31 Dec 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.18%
18,980
$92,622 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
0.17%
17,959
$87,640 31 Dec 2025
13F
STATE STREET CORP
13F
Company
0.15%
15,698
$76,606 31 Dec 2025
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
15,180
$74,078 31 Dec 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.13%
13,601
$66,373 31 Dec 2025
13F
Heron Bay Capital Management
13F
Company
0.13%
13,471
$65,738 31 Dec 2025
13F
Cannell & Spears LLC
13F
Company
0.1%
11,000
$53,680 31 Dec 2025
13F
Centiva Capital, LP
13F
Company
0.1%
10,835
$52,875 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
0.1%
10,828
$52,841 31 Dec 2025
13F
ELKHORN PARTNERS LIMITED PARTNERSHIP
13F
Company
0.07%
7,000
$34,160 31 Dec 2025
13F
Kestra Advisory Services, LLC
13F
Company
0.06%
6,015
$29,353 31 Dec 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.02%
1,625
$7,930 31 Dec 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
738
$4,000 31 Dec 2025
13F
SageView Advisory Group, LLC
13F
Company
0.01%
590
$2,880 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
73
$356 31 Dec 2025
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
50
$244 31 Dec 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
31
$151 31 Dec 2025
13F
NewEdge Advisors, LLC
13F
Company
0%
27
$132 31 Dec 2025
13F
Robert R. Banks Jr.
3/4/5
President and CEO
mixed-class rows
427,165
mixed-class rows
$1,880,603 23 Mar 2026
Oliver Spandow Power
3/4/5
Director
mixed-class rows
129,931
mixed-class rows
$614,573 10 Nov 2025
Arthur H. Amron
3/4/5
Director
mixed-class rows
141,932
mixed-class rows
$570,566 16 Mar 2026
Judy Krandel Power
3/4/5
Chief Financial Officer
mixed-class rows
122,524
mixed-class rows
$551,766 23 Mar 2026
Daron Evans
3/4/5
CEO Specialty Renal Products
mixed-class rows
179,718
mixed-class rows
$351,795 24 May 2021
Andrew Astor Power
3/4/5
President, CEO & CFO, Director
mixed-class rows
131,385
mixed-class rows
$204,342 05 Mar 2022
Alisa Lask
3/4/5
Director
mixed-class rows
55,679
mixed-class rows
$109,167 01 Jan 2025
Tom Gwydir Power
3/4/5
Director
mixed-class rows
50,306
mixed-class rows
$95,210 05 Jan 2023
Wesley S. Lobo
3/4/5
Chief Marketing Officer
mixed-class rows
206,714
mixed-class rows
$77,461 16 Feb 2022
Lisa Nettis Power
3/4/5
Director
mixed-class rows
14,851
mixed-class rows
$70,245 10 Nov 2025
Joseph Michael Harris
3/4/5
Director
mixed-class rows
24,743
mixed-class rows
$39,719 01 Jan 2025

Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q1 2026

As of 31 Mar 2026, NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,370,279 shares. The largest 10 holders included WEXFORD CAPITAL LP, Topline Capital Management, LLC, VANGUARD CAPITAL MANAGEMENT LLC, Cornerstone Capital, Inc., BARD ASSOCIATES INC, Mesirow Financial Investment Management, Inc., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and HighTower Advisors, LLC. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
35
Q1 2026 holders
27
Holder diff
-8
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .